4.7 Article

Brown adipose tissue dysfunction promotes heart failure via a trimethylamine N-oxide-dependent mechanism

Journal

SCIENTIFIC REPORTS
Volume 12, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-022-19245-x

Keywords

-

Funding

  1. MEXT [20H00533]
  2. AMED [JP20ek0210114]
  3. AMED-CREST [JP20gm1110012, JP20gm1010009]
  4. Moonshot Research and Development Program [21zf0127003s0201]
  5. MEXT
  6. Private University Research Branding Project, and Leading Initiative for Excellent Young Researchers
  7. Takeda Medical Research Foundation
  8. Vehicle Racing Commemorative Foundation
  9. Ono Medical Research Foundation
  10. Suzuken Memorial Foundation
  11. Uehara Memorial Foundation
  12. Kowa Life Science Foundation
  13. Manpei Suzuki Diabetes Foundation
  14. SENSHIN Medical Research Foundation
  15. Tsukada Grant for Niigata University Medical Research
  16. Nakajima Foundation
  17. HOKUTO Corporation
  18. Mochida Memorial Foundation for Medical & Pharmaceutical Research [16H06244]
  19. Daiichi Sankyo Foundation of Life Science
  20. AMED Project for Elucidating and Controlling Mechanisms of Aging and Longevity [JP17gm5010002, JP18gm5010002, JP19gm5010002, JP20gm5010002, JP21gm5010002]
  21. Astellas Foundation for Research on Metabolic Disorders
  22. Naito Foundation
  23. Japan Geriatrics Society
  24. Yujin Memorial Grant
  25. Sakakibara Memorial Research Grant from The Japan Research Promotion Society for Cardiovascular Diseases
  26. TERUMO Life Science Foundation
  27. Kanae Foundation
  28. JST ERATO [JPMJER1902]
  29. Takeda Science Foundation
  30. Food Science Institute Foundation
  31. Bourbon
  32. [26893080]
  33. [19K08974]

Ask authors/readers for more resources

This study demonstrates that dysfunction of brown adipose tissue (BAT) is involved in the development of heart failure through choline metabolism disorientation. The research shows that BAT thermogenic capacity is reduced in mice with thoracic aortic constriction or myocardial infarction, leading to decreased body temperature. Moreover, hypoxia induces apoptosis of brown adipocytes. Enhancement of BAT function improves cardiac function, while genetic BAT dysfunction impairs systolic function.
Low body temperature predicts a poor outcome in patients with heart failure, but the underlying pathological mechanisms and implications are largely unknown. Brown adipose tissue (BAT) was initially characterised as a thermogenic organ, and recent studies have suggested it plays a crucial role in maintaining systemic metabolic health. While these reports suggest a potential link between BAT and heart failure, the potential role of BAT dysfunction in heart failure has not been investigated. Here, we demonstrate that alteration of BAT function contributes to development of heart failure through disorientation in choline metabolism. Thoracic aortic constriction (TAC) or myocardial infarction (MI) reduced the thermogenic capacity of BAT in mice, leading to significant reduction of body temperature with cold exposure. BAT became hypoxic with TAC or MI, and hypoxic stress induced apoptosis of brown adipocytes. Enhancement of BAT function improved thermogenesis and cardiac function in TAC mice. Conversely, systolic function was impaired in a mouse model of genetic BAT dysfunction, in association with a low survival rate after TAC. Metabolomic analysis showed that reduced BAT thermogenesis was associated with elevation of plasma trimethylamine N-oxide (TMAO) levels. Administration of TMAO to mice led to significant reduction of phosphocreatine and ATP levels in cardiac tissue via suppression of mitochondrial complex IV activity. Genetic or pharmacological inhibition of flavin-containing monooxygenase reduced the plasma TMAO level in mice, and improved cardiac dysfunction in animals with left ventricular pressure overload. In patients with dilated cardiomyopathy, body temperature was low along with elevation of plasma choline and TMAO levels. These results suggest that maintenance of BAT homeostasis and reducing TMAO production could be potential next-generation therapies for heart failure.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available